BR112016014758A8 - composto e método para a marcação radioativa e composição farmacêutica compreendendo o referido composto - Google Patents
composto e método para a marcação radioativa e composição farmacêutica compreendendo o referido composto Download PDFInfo
- Publication number
- BR112016014758A8 BR112016014758A8 BR112016014758A BR112016014758A BR112016014758A8 BR 112016014758 A8 BR112016014758 A8 BR 112016014758A8 BR 112016014758 A BR112016014758 A BR 112016014758A BR 112016014758 A BR112016014758 A BR 112016014758A BR 112016014758 A8 BR112016014758 A8 BR 112016014758A8
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- radioactive labeling
- present
- pharmaceutical composition
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Abstract
a presente invenção fornece métodos para a marcação radioativa de compostos úteis como inibidores de hsp90. a presente invenção também fornece intermediários úteis em tais métodos, e composições de compostos marcados radioativamente. a presente invenção fornece, entre outras coisas, novos métodos para a síntese de compostos marcados radioativamente. em certas formas de realização, a presente invenção fornece compostos de fórmula i.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361919901P | 2013-12-23 | 2013-12-23 | |
| PCT/US2014/072090 WO2015138039A1 (en) | 2013-12-23 | 2014-12-23 | Methods and reagents for radiolabeling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112016014758A2 BR112016014758A2 (pt) | 2017-08-08 |
| BR112016014758A8 true BR112016014758A8 (pt) | 2020-06-02 |
Family
ID=54072256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016014758A BR112016014758A8 (pt) | 2013-12-23 | 2014-12-23 | composto e método para a marcação radioativa e composição farmacêutica compreendendo o referido composto |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9994573B2 (pt) |
| EP (1) | EP3086792B1 (pt) |
| JP (1) | JP6491214B2 (pt) |
| KR (1) | KR102325454B1 (pt) |
| CN (1) | CN106456645B (pt) |
| AU (1) | AU2014386214B2 (pt) |
| BR (1) | BR112016014758A8 (pt) |
| CA (1) | CA2934850C (pt) |
| IL (1) | IL246403B (pt) |
| MX (1) | MX2016008418A (pt) |
| RU (1) | RU2016128528A (pt) |
| TW (1) | TWI673279B (pt) |
| WO (1) | WO2015138039A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015138039A1 (en) | 2013-12-23 | 2015-09-17 | Memorial Sloan-Kettering Cancer Center | Methods and reagents for radiolabeling |
| AU2015317632B2 (en) * | 2014-09-17 | 2022-01-13 | Memorial Sloan Kettering Cancer Center | Hsp90-targeted inflammation and infection imaging and therapy |
| US10812036B2 (en) * | 2015-06-30 | 2020-10-20 | Hitachi Kokusai Electric Inc. | Matching box and matching method |
| KR102175125B1 (ko) * | 2018-12-28 | 2020-11-05 | 울산과학기술원 | 미토콘드리아 표적 Hsp90 억제제 기반 화합물 및 이를 포함하는 광역학 치료를 위한 약학적 조성물 |
| WO2022182731A1 (en) * | 2021-02-24 | 2022-09-01 | Samus Therapeutics, Inc. | Sn-labeling and radiolabeling of epichaperome inhibitors |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| WO2005012482A2 (en) * | 2003-06-30 | 2005-02-10 | Sloan-Kettering Institute For Cancer Research | Assay for identification of bioactive compounds that interact with heat shock protein 90 |
| US9403828B2 (en) | 2005-02-01 | 2016-08-02 | Sloan-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
| US7834181B2 (en) | 2005-02-01 | 2010-11-16 | Slaon-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
| AU2007249194B2 (en) | 2006-05-12 | 2012-11-22 | Myrexis, Inc. | Therapeutic compounds and their use in cancer |
| CA2656202C (en) | 2006-06-30 | 2018-01-16 | Sloan-Kettering Institute For Cancer Research | Treatment of neurodegenerative diseases through inhibition of hsp90 |
| AU2008229216B2 (en) | 2007-03-20 | 2013-03-21 | Curis, Inc. | Fused amino pyridine as HSP90 inhibitors |
| JP2011503206A (ja) | 2007-11-14 | 2011-01-27 | ミレクシス， インコーポレイテッド | 疾患および障害の治療における治療化合物およびその使用方法 |
| BR112012008019A2 (pt) | 2009-10-07 | 2016-03-01 | Sloan Kettering Inst Cancer | derivados de purina úteis como inibidores de hsp90 |
| MX360390B (es) | 2011-04-05 | 2018-10-31 | Sloan Kettering Inst Cancer Res | Inhibidores de la proteina 90 de choque termico (hsp90). |
| ES2647889T3 (es) | 2011-04-05 | 2017-12-27 | Sloan-Kettering Institute For Cancer Research | Inhibidores de la Hsp90 |
| CA2833390A1 (en) | 2011-04-28 | 2012-11-01 | Sloan-Kettering Institute For Cancer Research | Hsp90 combination therapy |
| CA2841173C (en) | 2011-07-08 | 2022-06-21 | Sloan-Kettering Institute For Cancer Research | Uses of labeled hsp90 inhibitors |
| AU2014228822A1 (en) * | 2013-03-15 | 2015-10-01 | Memorial Sloan-Kettering Cancer Center | HSP90-targeted cardiac imaging and therapy |
| JP6539275B2 (ja) * | 2013-08-16 | 2019-07-03 | メモリアル スローン ケタリング キャンサー センター | 選択的ｇｒｐ９４阻害剤およびその使用 |
| WO2015138039A1 (en) | 2013-12-23 | 2015-09-17 | Memorial Sloan-Kettering Cancer Center | Methods and reagents for radiolabeling |
| AU2015317632B2 (en) | 2014-09-17 | 2022-01-13 | Memorial Sloan Kettering Cancer Center | Hsp90-targeted inflammation and infection imaging and therapy |
| TW201722422A (zh) | 2015-10-05 | 2017-07-01 | 美國紀念斯隆-凱特琳癌症中心 | 用於治療癌症之合理組合療法 |
-
2014
- 2014-12-23 WO PCT/US2014/072090 patent/WO2015138039A1/en active Application Filing
- 2014-12-23 TW TW103145077A patent/TWI673279B/zh not_active IP Right Cessation
- 2014-12-23 CA CA2934850A patent/CA2934850C/en active Active
- 2014-12-23 EP EP14885717.0A patent/EP3086792B1/en active Active
- 2014-12-23 AU AU2014386214A patent/AU2014386214B2/en active Active
- 2014-12-23 JP JP2016542216A patent/JP6491214B2/ja not_active Expired - Fee Related
- 2014-12-23 BR BR112016014758A patent/BR112016014758A8/pt not_active Application Discontinuation
- 2014-12-23 CN CN201480076193.7A patent/CN106456645B/zh active Active
- 2014-12-23 RU RU2016128528A patent/RU2016128528A/ru unknown
- 2014-12-23 MX MX2016008418A patent/MX2016008418A/es unknown
- 2014-12-23 US US15/107,229 patent/US9994573B2/en active Active
- 2014-12-23 KR KR1020167019985A patent/KR102325454B1/ko active IP Right Grant
-
2016
- 2016-06-22 IL IL246403A patent/IL246403B/en active IP Right Grant
-
2018
- 2018-05-04 US US15/971,908 patent/US10329293B2/en active Active
-
2019
- 2019-04-26 US US16/396,496 patent/US10793570B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN106456645A (zh) | 2017-02-22 |
| JP6491214B2 (ja) | 2019-03-27 |
| US10329293B2 (en) | 2019-06-25 |
| BR112016014758A2 (pt) | 2017-08-08 |
| AU2014386214B2 (en) | 2020-05-21 |
| CN106456645B (zh) | 2021-03-23 |
| TW201609773A (zh) | 2016-03-16 |
| TWI673279B (zh) | 2019-10-01 |
| CA2934850A1 (en) | 2015-09-17 |
| EP3086792A1 (en) | 2016-11-02 |
| EP3086792A4 (en) | 2017-05-24 |
| IL246403A0 (en) | 2016-08-31 |
| AU2014386214A1 (en) | 2016-07-14 |
| RU2016128528A (ru) | 2018-01-30 |
| CA2934850C (en) | 2022-12-06 |
| KR102325454B1 (ko) | 2021-11-16 |
| JP2017502039A (ja) | 2017-01-19 |
| US9994573B2 (en) | 2018-06-12 |
| WO2015138039A1 (en) | 2015-09-17 |
| EP3086792B1 (en) | 2022-10-12 |
| MX2016008418A (es) | 2017-01-11 |
| US10793570B2 (en) | 2020-10-06 |
| US20200017502A1 (en) | 2020-01-16 |
| IL246403B (en) | 2020-08-31 |
| US20180251461A1 (en) | 2018-09-06 |
| US20170029426A1 (en) | 2017-02-02 |
| KR20160101186A (ko) | 2016-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015002394A1 (es) | Inhibidores de histona desmetilasas | |
| CU24309B1 (es) | Compuestos derivados tienopirimidina y composiciones farmacéuticas que los contienen | |
| BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
| CR20180057A (es) | Nuevos compuestos biciclicos como inhibidores duales de atx/ca. | |
| EA201591961A1 (ru) | Ингибиторы акк и их применение | |
| BR112016006209A2 (pt) | composição de polímero termoplástico | |
| EA201591959A1 (ru) | Ингибиторы акк и их применение | |
| MX362582B (es) | Compuestos triciclicos fusionados de urea como inhibidores de raf quinasa y/o dimero de raf quinasa. | |
| EA201591960A1 (ru) | Ингибиторы акк и их применение | |
| CR20180072A (es) | Nuevos compuestos biciclicos como inhibidores de atx | |
| BR112014012543A2 (pt) | métodos e materiais para síntese enzimática de compostos de mogrosídeo | |
| CR20180143A (es) | Nuevos compuestos biciclicos como inhibidores duales de atx/ca | |
| ECSP11011390A (es) | Compuestos espiro-amidas sustituidas | |
| UY35683A (es) | Polimorfo de inhibidores de tirosina quinasa de bazo (syk) | |
| ECSP13012519A (es) | Compuestos sustituidos de benzamida | |
| EA201690473A1 (ru) | Комбинированный состав двух противовирусных соединений | |
| EA201591962A1 (ru) | Ингибиторы акк и их применение | |
| CR20140089A (es) | Nuevos derivados bicíclicos de dihidroquinolina-2-ona | |
| CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| BRPI1012638B8 (pt) | métodos e intermediários para preparar agentes farmacêuticos | |
| UY32704A (es) | Compuestos de 2,3-dihidro-1h-indeno | |
| CR20140217A (es) | Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas ii | |
| BR112016014758A8 (pt) | composto e método para a marcação radioativa e composição farmacêutica compreendendo o referido composto | |
| CU24366B1 (es) | Compuestos que poseen un anillo que contiene nitrógeno salicílico unido a un grupo heteroarilo bicíclico útiles como inhibidores rorc2 | |
| MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |